Bridgeway Capital Management, LLC Codex Dna, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.14 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
N/A
-50,000 Reduced 42.74%
67,000 $123,000
Q3 2022

Nov 14, 2022
BUY
$1.7 - $2.36 $198,900 - $276,120
117,000 New
117,000 $194,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0
View Full List

About Codex DNA, Inc.

DNAY Quotes by TradingView
  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email